In order to clarify a role of stromal cells in sex steroidal neovascularization, plasminogen activator inhibitor (PAI)-l [an inhibitor of tissuetype plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)] and its messenger ribonucleic acid (mRNA) were analysed in fibroblasts derived from uterine endometrium as a model for endometrial stromal cells under the influence of sex steroids. The determinations were carried out by an enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction-Southern blotting, respectively.
SUMMARY. In order to clarify a role of stromal cells in sex steroidal neovascularization, plasminogen activator inhibitor (PAI)-l [an inhibitor of tissuetype plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)] and its messenger ribonucleic acid (mRNA) were analysed in fibroblasts derived from uterine endometrium as a model for endometrial stromal cells under the influence of sex steroids. The determinations were carried out by an enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction-Southern blotting, respectively.
In the fibroblasts, either estradiol or progestogens (progesterone, medroxy progesterone acetate or 17oc:hydroxyprogesterone) induced expressions of PAI-l and its mRNA, and their combination further increased their expression by approximately twofold. PAI-l from endometrial stromal cells under the influence of sex steroids might contribute to endometrial neovascularization through its effect on endothelial cells in endometrial vessels.
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The turnover of capillary endothelial cells is generally very slow taking months or years for physiological neovascularization, while the turnover of cells in uterine endometrium is rapidly altered in response to the cycle of ovarian steroids.' In particular, the endothelial cells are renewed from degenerated coiled arteries, migrate into the endometrium and form microvessel tubes during the menstrual cycle.?
Neovascularization consists of the following steps: angiogenic factors activate some proteases, which dissolve endothelial basement membrane. This is followed by migration and proliferation of endothelial cells, resulting in capillary tube formation.' Basic fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factors (TGF)-oc and p, and vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) are recognized as the angiogenic factors.v? These Correspondence: Jiro Fujimoto MD PhD. factors induce synthesis of plasminogen activator (PA) in vascular endothelial cells. PA dissolves fibronectin, and converts plasminogen to plasmin, a serine protease. Plasmin dissolves laminin and fibronectin in extracellular matrices, and activates collagenase to dissolve basement membrane collagen.8-10 Therefore, it may be concluded that dissolution of the extracellular matrix is regulated by PA and plasminogen activator inhibitor (PAI)-l under the influence of ovarian sex steroids.
Although the details of cellular interactions in the endometrium is not well understood, it seems plausible that the paracrine action of PAI-l from epithelial and stromal cells on vascular endothelial cells might contribute to the initiation of the early stages of neovascularization. In order to investigate this role of stromal cells in sex steroid mediated neovascularization, we investigated the effect of sex steroids on the expression of PAI-l and its mRNA in fibroblasts derived from uterine endometrium.
MATERIALS AND METHODS

Steroids
Estradiol-I 7fl, tetrahydrocortisol, hydrocortisone, progesterone, medroxyprogesterone acetate (MP A), and 170(-hydroxyprogesterone were purchased from Sigma Chemical Co (St Louis, MO, USA). Hormones were solubilized in ethanol, and added to the culture medium with a final concentration of ethanol below 0·1 %.
Preparation of fibroblasts derived from endometria Human endometria were obtained from patients treated by hysterectomy for uterine leiomyoma at the Department of Obstetrics and Gynecology, Gifu University School of Medicine. Informed consent was obtained from all patients, whose age ranged from 33 to 42 years and who all had regular menstrual cycles.
The endometrial fibroblasts were cultured according to our published methods. II Fetal bovine serum (FBS) was treated with 10% dextran-coated charcoal (DCC) for 16 h to remove all free steroids, and all media were phenol red-free. Fibroblasts were cultured in 90% Eagle's minimum essential medium (MEM) and 10% FBS treated with DCC. For the steroid studies fibroblasts were incubated in the conventional media without FBS, and with or without estradiol and/or progesterone at the final concentrations of 10-12 to 10-6 M for the times indicated.
Determination of human PAI-l antigen by enzyme immunoassay All steps were carried out at 4°C, except where indicated. The cells (1G-20 mg) were homogenized in HG buffer (5 mM Tris-HCI, pH 7-4, 5mM NaCl, 1mM CaCI 2, 2mM ethyleneglycolbis-[fl-aminoethyl ether]-N,N,N',N' -tetraacetic acid, 1mM MgCI 2, 2 mM dithiothreitol (DTT), 25/lg/mL aprotinin, and 25 /lg/mL leupeptin) by a Polytron homogenizer (Kinematics, Lucern, Switzerland). The suspension was centrifuged in a microfuge at 12000rpm for 3min to remove the nuclear pellet.
PAI-l antigen levels in the cells treated with sex steroids were determined by enzyme-linked immunosorbent assay (ELISA) using a TintElize PAI-I kit (Biopool AB, Umea, Sweden). The protein concentration of samples was measured by the Bradford method'? and results were expressed as ng PAI-I per mg protein.
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Reverse transcription-polymerase chain reaction (PCR) and Southern blot analysis for quantification of PAI-l mRNA Total RNA isolated from the fibroblasts'? was reverse transcribed according to our previous method.'! Then 10 cycles of PCR for PAI-I mRNA, consisting of I min at 94°C for denaturation, I min at 55°C for annealing, and I min at noc for extension, were carried out with reverse transcribed cDNA and O.I/lM specific primers using an IWAKI thermal sequencer TSR-300 (Iwaki Glass, Tokyo, Japan), with Vent DNA polymerase (New England Biolabs, Beverly, MA, USA) in 20 mM Tris-HCl buffer pH 8'8, containing 10mM KCI, IOmM (NH4)2S04, 2mM MgS0 4, 0·1% triton-X-IOO, and 0·15 mM deoxynucleotide phosphates. An additional 20 cycles of PCR for PAI-I mRNA and glyceraldehyde-3-phosphate dehydrogenase mRNA (GAPDH) as an internal standard were performed in the same tube.
Oligodeoxynucleotide primers for the PCR of PAI-I and GAPDH cDNAs were synthesized according to published sequences'<" as follows: sense for PAI-I mRNA, Southern blot analysis for quantification of PAI-I mRNA expression was carried out according to published methods.'! The intensity of specific bands was standardized against that of GAPDH mRNA.
Statistical analysis was performed using Student's t-test; differences were considered significant when P was less than 0·05.
RESULTS
Dose-response curve of PAI-l expression induced by estradiol or progesterone in endometrial fibroblasts
Both estradiol and progesterone increased the expression of PAI-I during 48 h incubation dose-dependently, up to 1O-8 M , (P<0·05) (Fig. I) .
From this dose-response curve, the concentrations of estradiol and progesterone of 10-8 M was chosen for the following time course studies. Time course of PAI-l expression induced by estradiol and/or progesterone in endometrial fibroblasts Both estradiol and progesterone significantly increased (P< 0,05) the level of PAI-l within 6 h. The level of PAI-l was almost doubled by a combination of estradiol and progesterone (Fig. 2 ).
Effects of various steroids on the expression of PAI-l in endometrial fibroblasts
Neither tetrahydrocortisol nor hydrocortisone (10-8 M) with or without estradiol altered significantly the level of PAl-I after 48 h incubation (Fig. 3) . Progestogens [either progesterone, MPA or l71X-hydroxyprogesterone (10-8 M)] with or without estradiol increased significantly (P<0·05) the level of PAI-l after 48h incubation ( Fig. 3 ).
Dose-response curve of PAI-l mRNA expression induced by estradiol or progesterone in endometrial fibroblasts
Both estradiol and progesterone increased the level of PAI-l mRNA dose-dependently, up to 10-8 M, after 48 h incubation (Figs 4a,b) .
Based on this dose response, the concentration of estradiol and progesterone of 10-8 M was chosen for the following time course studies. TImecoune of PAI-l mRNA expression iaduced by estradiol _lor progesterone la endometrial fibrobluts Both estradiol and progesterone significantly increased (P<0·05) the level of PAl-I mRNA within 6 h. The increase was almost doubled by a combination of estradiol and progesterone after 12h incubation (Figs Sa and b) .
Effects of various steroids on the expression of PAI·l mRNA la endometrial fibrobluts
Neither tetrahydrocortisol nor hydrocortisone (10-8 M) with or without estradiol altered significantly the level of PAl-I mRNA after 48 h incubation (Figs 6a,b) .
Progestogens [either progesterone, MPA or 17a-hydroxyprogesterone (10-8 M») with or without estradiol increased significantly (P<0'05) the level of PAI·I mRNA following 48 h incubation (Figs 6a.b ).
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Uterine endometrium consists of epithelial and stromal cells. Therefore, the fibroblasts from uterine endometrium are used as an experimental substitute for stromal cells. In the early stage of neovascularization, vascular endothelial basement membrane is dissolved by plasmin and plasmin-associated protease which are activated by angiogenic factors. In the present study, estradiol and/or progesterone induced the expression of PAI-I and its mRNA in the endometrial fibroblasts. On the other hand, tetrahydrocortisol, 17a-hydroxyprogesterone, and hydrocortisone exert an angiostatic effect on endothelial cells." However, tetrahydrocortisol or hydrocortisone did not alter the levels of PAI-I and its mRNA with or without estradiol in the fibroblasts. Progestogens (progesterone, MPA or 17a-hydroxyprogesterone) with or without estradiol increased the expression of PAl-I and its mRNA by approximately twofold in the fibroblasts. Since fibroblasts conserve estrogen and progesterone receptors,'? these steroids might exert a synergistic effect on the induction of PAI·I and its mRNA expression. In fact, capillary vessel neovascularization is ended by the progestational or secretory phase of the menstrual cycle (after ovulation). This implies an intimate synergistic association between sex steroids and PAI-I expression.
The expression of endometrial basic FGF, one of the angiogenic factors, is induced by estrogen, while progesterone diminishes the estrogeninduced events after ovulation." Basic FGF induces PA and plasmin synthesis in endothelial cells of endometrial vessels," The paracrine supply of estrogen/progesterone-induced PAl-I from endometrial stromal cells to endothelial cells in endometrial vessels might contribute to the downregulation of endometrial neovascularization, especially after ovulation during the menstrual cycle. 
